To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Dunn Labortechnik celebrates its 30th anniversary
01-02-2012: In 1982 the company Dunn Labortechnik was founded in Asbach (Germany) by Hannelore and Peter Dunn. Since then, the company has supplied research and routine laboratories with equipment, disposables as well as immunoreagents, plasma and sera and has evolved from a nationally to an internationally operating company.
Researchers from academia and industry have come to rely on the professional and competent services offered by Dunn Labortechnik. Led by a dedicated Management, the Team consists of qualified scientists responsible for product management, competent and friendly sales and logistics staff, as well as highly trained technicians.
The extensive product range of Dunn Labortechnik includes liquid handling systems, laminar airflow cabinets, incubators and roller devices as well as a large selection of immunoreagents and a wide choice of single use consumables and glass products. With its product range, reliable and efficient service, Dunn Labortechnik has acquired recognition in the areas of Life Science and Biotechnology. The company has focused on products for cell and tissue culture laboratories, protein crystallization, microbiology and molecular biology.
Company founder and Managing Director Hannelore Dunn: "We thank all our customers and suppliers for their loyalty and look forward to a continued good relationship with our existing and new customers in order to support their research activities with our products and services".
Contact / Request information
Request further information free of charge:
Watchlist
This is where you can add this news to your personal favourites
- 1Pro Bono Bio Launches Flexiseq: A Novel Approach to the Treatment of Osteoarthritis
- 2Fighting listeria and other food-borne illnesses with nanobiotechnology
- 3Using human brain cells to make mice smarter
- 4A light switch inside the brain
- 5Pharma’s New Hero: Supergenerics Save Money and Improve Drugs
- 6Rosetta Resolver® Gene Expression Data Analysis System licensed by Aventis Pharmaceuticals, Inc.
- 7Vivacta Initiates Development of Point of Care Test for Vitamin D
- 8Researchers divide enzyme to conquer genetic puzzle
- 9New study confirms fungal infection of the foot is a risk factor for bacterial tissue infection of the leg
- 10Bayer’s Novel Anticoagulant Xarelto now also Approved in the EU
- Carl Zeiss Meditec improves its results in first six months of financial yea ...
- Evonik selects OPX Biotechnologies for joint development of bio-based chemicals
- Frost & Sullivan commends Merck Serono for its excellence in product differe ...
- SYGNIS reports results for the first quarter of 2013
- ZEISS presents half-year financial figures
- Evotec and Harvard University to collaborate on development of new class of antibacterials
- Carl Zeiss Meditec improves its results in first six months of financial year 2012/2013
- Evonik selects OPX Biotechnologies for joint development of bio-based chemicals
- Frost & Sullivan commends Merck Serono for its excellence in product differentiation
- SYGNIS reports results for the first quarter of 2013
